Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v4-FR Version v3-EN
Language French English
Date Updated 2022-03-14 2022-03-14
Drug Identification Number 02243895 02243895
Brand name TAZORAC TAZORAC
Common or Proper name Tazarotene Cream Tazarotene Cream
Company Name ALLERGAN INC ALLERGAN INC
Ingredients TAZAROTENE TAZAROTENE
Strength(s) 0.1% 0.1%
Dosage form(s) CREAM CREAM
Route of administration TOPICAL TOPICAL TOPICAL TOPICAL
Packaging size 30g, 3.5g 30g, 3.5g
ATC code D05AX D05AX
ATC description ANTIPSORIATICS FOR TOPICAL USE ANTIPSORIATICS FOR TOPICAL USE
Reason for discontinuation Business reasons Business reasons
Anticipated discontinuation date 2022-02-01 2022-02-01
Actual discontinuation date 2022-02-25 2022-02-25
Remaining supply date 2022-02-01 2022-02-01
Discontinuation status Discontinued Discontinued
Discontinuation decision reversal no no
Tier 3 Status No No
Information on remaining supply
Company comments
Health Canada comments